Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 4
1951 1
1956 1
1957 1
1959 3
1960 3
1962 1
1963 1
1982 3
1984 1
1985 3
1990 1
1991 1
1992 4
1993 4
1994 1
1995 2
1996 3
1997 2
1998 2
1999 3
2000 1
2001 3
2002 1
2003 3
2004 2
2006 3
2007 3
2008 2
2009 2
2010 3
2011 2
2012 3
2013 1
2014 3
2015 5
2016 7
2017 10
2018 12
2019 21
2020 28
2021 37
2022 22
2023 25
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Results by year

Filters applied: . Clear all
Page 1
Biologics and airway remodeling in severe asthma.
Varricchi G, Ferri S, Pepys J, Poto R, Spadaro G, Nappi E, Paoletti G, Virchow JC, Heffler E, Canonica WG. Varricchi G, et al. Among authors: spadaro g. Allergy. 2022 Dec;77(12):3538-3552. doi: 10.1111/all.15473. Epub 2022 Aug 23. Allergy. 2022. PMID: 35950646 Free PMC article. Review.
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases.
Maniscalco M, Fuschillo S, Mormile I, Detoraki A, Sarnelli G, Paulis A, Spadaro G, Cantone E; PATH-2 TASK FORCE. Maniscalco M, et al. Among authors: spadaro g. Cells. 2023 Oct 25;12(21):2518. doi: 10.3390/cells12212518. Cells. 2023. PMID: 37947596 Free PMC article. Review.
Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
Riedl MA, Tachdjian R, Lumry WR, Craig T, Karakaya G, Gelincik A, Stobiecki M, Jacobs JS, Gokmen NM, Reshef A, Gompels MM, Manning ME, Bordone L, Newman KB, Treadwell S, Wang S, Yarlas A, Cohn DM; OASIS-HAE Team. Riedl MA, et al. N Engl J Med. 2024 Jul 4;391(1):21-31. doi: 10.1056/NEJMoa2402478. Epub 2024 May 31. N Engl J Med. 2024. PMID: 38819395 Clinical Trial.
Editorial: The Complexity of Primary Antibody Deficiencies.
Quinti I, Spadaro G, Jolles S, Condino-Neto A. Quinti I, et al. Among authors: spadaro g. Front Immunol. 2021 Apr 21;12:635482. doi: 10.3389/fimmu.2021.635482. eCollection 2021. Front Immunol. 2021. PMID: 33968027 Free PMC article. No abstract available.
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
Nolasco S, Portacci A, Campisi R, Buonamico E, Pelaia C, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Crimi N, Scichilone N, Pelaia G, Carpagnano GE, Crimi C. Nolasco S, et al. Among authors: spadaro g. Front Immunol. 2023 Jun 30;14:1204444. doi: 10.3389/fimmu.2023.1204444. eCollection 2023. Front Immunol. 2023. PMID: 37457743 Free PMC article.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Portacci A, Campisi R, Buonamico E, Nolasco S, Pelaia C, Crimi N, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Scichilone N, Pelaia G, Crimi C, Carpagnano GE. Portacci A, et al. Among authors: spadaro g. ERJ Open Res. 2023 Oct 30;9(5):00419-2023. doi: 10.1183/23120541.00419-2023. eCollection 2023 Sep. ERJ Open Res. 2023. PMID: 37908397 Free PMC article.
237 results